findmyKOL

Sameer Gafoor, MD

Basic profile

Swedish Medical Center

ORCIDNone on fileNPI
RegionSeattle, WA · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sameer Gafoor is a Cardiology physician affiliated with Swedish Medical Center. OpenAlex indexes 156 publications with 4,434 citations (h-index 32).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
156publications

Distinct works indexed by OpenAlex.

4,434citations

Total citations across indexed works.

32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

550 17th Ave Fl 6
Seattle, WA 981225788

Telephone

206-215-4545

Provider last certified this registry record 16 Dec 2024.

View the NPPES registry record

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    64.4%
    Aldosterone antagonist (MRA)15.7%
    Spironolactone100%
    Part D21 patients
    Beta blocker14.5%
    Metoprolol Succinate54%Metoprolol Tartrate28%Carvedilol19%
    Part D<11 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    17.4%
    SGLT2 inhibitor17.4%
    Jardiance67%Farxiga33%
    Part D<11 patients
  • Blood & clotting

    12.5%
    P2Y12 inhibitor9.6%
    Clopidogrel100%
    Part D22 patients
    Factor Xa inhibitor2.9%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)49.2% facility · 50.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”